Home › Type 2 Diabetes › Pennsylvania › Philadelphia
Type 2 Diabetes clinical trials in Philadelphia, PA
15 studies for Type 2 Diabetes are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RecruitingPhase 2
- Suburban Research Associates, West Chester · 24 mi away
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Thomas Jefferson University, Philadelphia
- Tristar Clinical Investigations PC, Philadelphia
- Suburban Research Associates, West Chester · 24 mi away
Phenotyping Genetic Risk for Type 2 Diabetes
RecruitingHealthy volunteers welcome
- Childrens Hospital of Philadelphia, Philadelphia
- University of Pennsylvania, Philadelphia
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RecruitingPhase 3
- AURORA-2 Clinical Site, Philadelphia
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
RecruitingPhase 2
- Suburban Research Associates, West Chester · 24 mi away
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
RecruitingPhase 3
- Research Site, Philadelphia
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
RecruitingPhase 2
- Suburban Research Associates, West Chester · 24 mi away
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
RecruitingPhase 3
- Children's Hosptl Philadelphia, Philadelphia
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
RecruitingPhase 3
- Children's Hospital of Philadelphia, Philadelphia
- St Christophers Hospital For Children, Philadelphia
The GRoceries Aimed at Increasing Nutrition Study
RecruitingMentions payment for participants
- University of Pennsylvania, Philadelphia
CGM for Management of Type 2 Diabetes in Pregnancy
Recruiting
- University of Pennsylvania, Philadelphia
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
Recruiting
- Children's Hospital of Philadelphia, Philadelphia
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
RecruitingObservational study
- Children's Hospital of Philadelphia, Philadelphia
Transformative Research in Diabetic Nephropathy 2.0
RecruitingObservational studyHealthy volunteers welcome
- Penn Presbyterian Medical Center, Philadelphia
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
Recruiting
- Thomas Jefferson University, Philadelphia
About Type 2 Diabetes
Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.
More about Type 2 Diabetes on MedlinePlus
Type 2 Diabetes trials in other cities
- San Antonio, TX37 studies
- Houston, TX31 studies
- Orlando, FL24 studies
- Boston, MA20 studies
- Miami, FL19 studies
- Chicago, IL19 studies
- Dallas, TX19 studies
- Columbus, OH18 studies
- Las Vegas, NV18 studies
- Atlanta, GA17 studies
- San Diego, CA17 studies
- Los Angeles, CA16 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Prostate Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.